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Abstract
The neonatal management of preterm born infants often results in damage to the develop-
ing lung and subsequent morbidity, referred to as bronchopulmonary dysplasia (BPD). Ani-
mal models may help in understanding the molecular processes involved in this condition
and define therapeutic targets. Our goal was to identify molecular pathways using the earlier
described preterm rabbit model of hyperoxia induced lung-injury. Transcriptome analysis by
mRNA-sequencing was performed on lungs from preterm rabbit pups born at day 28 of ges-
tation (term: 31 days) and kept in hyperoxia (95% O2) for 7 days. Controls were preterm
pups kept in normoxia. Transcriptomic data were analyzed using Array Studio and Ingenuity
Pathway Analysis (IPA), in order to identify the central molecules responsible for the
observed transcriptional changes. We detected 2217 significantly dysregulated transcripts
following hyperoxia, of which 90% could be identified. Major pathophysiological dysregula-
tions were found in inflammation, lung development, vascular development and reactive
oxygen species (ROS) metabolism. To conclude, amongst the many dysregulated tran-
scripts, major changes were found in the inflammatory, oxidative stress and lung develop-
mental pathways. This information may be used for the generation of new treatment
hypotheses for hyperoxia-induced lung injury and BPD.
Introduction
Preterm birth leads to a dysregulated development in many organs that are not yet adapted to
postnatal life. In the pulmonary system, this often results in bronchopulmonary dysplasia
(BPD), a complex disease in which multiple factors interact. Premature lungs (most frequently
in the saccular stage of lung development) are exposed to hyperoxic and hyperbaric conditions
during ventilation and administration of supplementary oxygen. This process is often
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amplified by pre- or postnatal infections, fluid imbalance, malnutrition, genetic predisposi-
tions, etc. Persistent inflammation overwhelms natural tissue repair and leads to an arrest in
alveolar development and vasculogenesis.[1] The resulting lung parenchyma is composed of
rudimentary alveoli, interstitial thickening and a dysmorphic capillary configuration.[2] These
morphological changes can be categorized as a developmental arrest.
The aforementioned risk factors are well-known and the application of less invasive ventila-
tion strategies and permissive hypoxemia have proven their efficacy. They became the corner-
stones of current neonatal management. [3,4] Despite this, BPD continues to be a frequent
complication of premature birth. About 15–25% of very low birth weight (VLBW) infants
develop BPD, and rates in extremely low birth weight (ELBW) infants are even higher.[5]
Moreover, BPD remains an important risk factor for lung disease later in life.[6]
At the molecular level BPD is still poorly studied compared to other pathologies. Several
individual molecules assessed in bronchoalveolar fluid have been proposed to play a key role in
BPD like interleukin-8 or matrix metalloproteinase-3.[7,8] Most studies however where
hypothesis driven or they examined certain pathways in lung disease and repair.
Animal models are needed to study disease mechanisms and to evaluate new preventive or
therapeutic strategies for BPD. Most research into BPD has been performed in hyperoxia-
exposed rodent models.[9–11] Unfortunately, their lung development differs from humans as
birth occurs in the early saccular stage of lung development. In rodents, alveolization only starts
several days postnatally while humans start alveolizing in utero. This entails that not all the rele-
vant findings can be extrapolated to the human context. As such, there is an advantage to study
the hyperoxia induced lung injury in animal models that mimic human development more
closely. The rabbit is considered a large animal model that has favorable characteristics for this
research question. In contrast to rodents, rabbits indeed start alveolizing prior to birth, as do
pigs, sheep, primates and humans.[12] Moreover, rabbits are easy to handle and house, have a
large litter size and allow technical manipulation of the fetus at relevant developmental stages
which makes them ideal for the study of effects of perinatal interventions. Therefore we used the
rabbit as a model for the study of hyperoxia-induced lung injury in the preterm born pup.[13]
Rather than focus on single putative molecule or pathways, we herein used a more complete
‘systems biology’-approach,[14] that allows the exploration of larger patterns and networks.
Herein we analyze transcriptome data using software (IPA) that combines expression data
with current generic knowledge of molecular interactions. Our goal was to obtain more com-
plete insights in the pathophysiology and generate new theoretical therapeutic strategies for
preterm hyperoxia induced lung injury.
Materials and Methods
Animal model
We earlier described in detail the preterm rabbit model for hyperoxia-induced lung injury.[13]
Briefly, time mated pregnant does underwent cesarean section at 28 days (term = 31 days) of
gestation (early saccular lung developmental phase). The pups were randomly divided into two
groups: (1) the normoxia group, where pups were housed in 21% oxygen and (2) the hyperoxia
group, where pups were nursed in hyperoxia ( 95% oxygen); both for seven days. The model
has been earlier described in detail elsewhere [15–17]. Briefly, immediately after delivery, pups
were placed in an incubator at 32°C, fed twice daily via an orogastric tube and received prophy-
lactic antibiotics and vitamin K. All animals were treated according to current guidelines of
animal well-being, and the experiments were approved by the Ethics Committee for Animal
Experimentation of the Faculty of Medicine of the Katholieke Universiteit Leuven (Leuven,
Belgium).
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Harvesting of specimens
At day 7 of life, pups were harvested for histological and transcriptome analysis. After eutha-
nizing the pups with a mixture of embutramide 200mg, mebezonium 50mg and tetracain
hydrochloride 5mg (intracardiac injection of 0.1mL T61, Intervet Belgium NV, Mechelen, Bel-
gium), thoracotomy was performed and both lungs and trachea were removed “en bloc”. The
left bronchus was ligated and the left lung was snap-frozen, while the right lung was processed
for histological analysis (see below). Six pups per group were used for histological analysis. Out
of the snap frozen samples, four left lungs from the normoxia group, and four from the hyper-
oxia group were randomly selected for transcriptome analysis.
Lung injury score
A 20G catheter was inserted in the trachea where after the right lung was fixed with 4% para-
formaldehyde by immersion and perfusion under a constant hydrostatic pressure of 25cm
H2O for 24 hours before embedding. Paraffin sections were stained with hematoxylin and
eosin (HE) for further histological analysis. Lung injury score was assessed on 20 random high-
power fields (400x total magnification) for each pup. The selection of random fields was
obtained by successive random displacements (each at least one high power field in length)
from the initial position provided that at least 50% of each field was occupied by lung alveoli. A
three-tiered scheme was used to quantify each of five histological parameters: presence of neu-
trophils in alveolar and interstitial space, hyaline membranes, debris filling the airspaces and
septal thickening.[18] The data were analyzed statistically using student-T test, significance
was set with a p-value< 0.05.
RNA isolation and sequencing
RNA isolation was performed on snap frozen lung tissue using the RNeasy mini kit (Qiagen).
Tissue lysis and homogenization was performed in 1200μL Buffer RLT using the TissueLyser
system (Qiagen). Following tissue disruption and homogenization, samples were centrifuged
for 3 min at 14000rpm in a benchtop micro centrifuge. Lysate was transferred to fresh tubes
and an equal volume of 70% ethanol was added. 600μL of sample was added twice to a spin col-
umn, with 2 RNeasy spin columns used per sample. Following wash steps RNA was eluted in
50μL RNAse-free H2O. Total RNA quantification was performed using the Nanodrop 1000
spectrophotometer (Thermo Scientific). RNA integrity was assessed using the RNA 6000 Nano
Kit and the Bioanalyser (Agilent Technologies) according to the manufacturer’s recommenda-
tions. Between 1 and 2μg of total RNA was used as input material for sequencing library prepa-
ration which was performed with the TruSeq RNA Library Preparation Kit (Illumina)
according to the manufacturers protocol. Fragmentation was performed for 6 minutes. 8 PCR
cycles were used for PCR enrichment step. Samples were indexed to allow for multiplexing.
Sequencing libraries were quantified using the Qubit fluorometer (Life Technologies). Library
quality and size range was assessed using the Bioanalyser (Agilent Technologies) with the
DNA 1000 Kit (Agilent Technologies) according to the manufacturer’s recommendations.
Individual libraries were diluted to a final concentration of 2nM and pooled for sequencing.
Pooled libraries were then sequenced in a single lane of an Illumina HiSeq2000 flow cell gener-
ating single end 50bp reads.
Data analysis
Expression values were calculated per gene and normalized to reads per kilobase per million
reads (RPKM) values as described by Mortazavi.[19] An RPKM value of>1 was applied as
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cut-off to distinguish between ‘noisy’ or ‘leaky’ transcription and ‘true’ mRNA expression levels
for comparison between samples. For comparison between both groups, fold changes (FC)
were calculated, indicating the ratio of expression. We applied a cut-off of>2 or<-2, in order
to decrease the number of transcripts in our analysis. False discovery rates (FDR) were calcu-
lated as a measure for statistical significance of the difference in expression of a gene between
the two groups. We considered a transcript change significant if FDR was<0.01.
Further analysis was performed using the Ingenuity Pathway Analysis (IPA) software. The
IPA ‘Upstream Regulator Analysis’ predicts upstream regulators by combining the directional
expression changes from our mRNA-sequencing, and knowledge from prior experimental
reports on causal effects between molecules (endogenous and exogenous), compiled in the IPA
Knowledge Base. Upstream Regulator Analysis calculates a z-score based on the edge of dysre-
gulation of all the downstream molecules and the uniformity of the existing evidence about the
upstream-downstream relation, for every upstream regulator known to have a causal effect on
at least 4 dysregulated transcripts. Z-scores of<-2 and>2 respectively indicate a significant
inhibition and activation state of the upstream regulator, regardless of the actual expression
level of these molecules.[20] The Network Generation Algorithm links molecules based on
experimentally observed interactions, and orders these molecule based on their interconnec-
tedness. In general, the more interactions with other network members, the more central a
molecule will be in a network.
Results
Lung injury score
Histological assessment of both normoxia as well as hyperoxia exposed lungs reveals a clear
increase in neutrophil infiltration and alveolar wall thickening (Fig 1A and 1B).[13] Generating
a combined lung injury score revealed a significant difference between both groups (Fig 1C)
with an increase in lung injury observed in animals held in hyperoxia (p<0.01).
Hyperoxia and gene expression profiles
We identified 2217 transcripts that were dysregulated (FDR< 0.01) in hyperoxia by at least a
factor 2 (FC>2 or FC<-2). A heat map of these genes visualizes a clear distinction between
hyperoxia and normoxia. (Fig 2). We were able to link IPA-gene names to 1989 of the 2217
dysregulated transcripts. This group was used for further analysis in IPA. 1023 of these tran-
scripts are upregulated in hyperoxia, with fold changes up to +235.786. The other 966 are
downregulated, as far down as -38.476. The ten most upregulated molecules in hyperoxia are
shown in Table 1, the ten most downregulated in Table 2. A complete list of these 1989 dysre-
gulated molecules can be found in S1 Table.
Pathway analysis of differentially expressed genes
Running the Upstream Regulator Analysis, we identified 58 inhibited and 160 activated signifi-
cant upstream regulators. Both endogenous and exogenous molecules are included in this anal-
ysis. All significant upstream regulators which are classified as transcription factors are
displayed in Table 3. All other upstream regulator types can be found in S2 Table. Significantly
dysregulated molecules were sorted by their function or involvement in pathophysiological
processes. An overview of the most relevant dysregulated molecules is provided in Table 4.
Inflammation. Although the inflammatory mediators are numerous, several appear to be
active molecules, such as interleukin 1A (IL1A, FC 6.864, FDR 3.6x10-3), interleukin 1B (IL1B,
FC 5.092, FDR 3.7x10-3), cyclo-oxygenase 2 (PTGS2 or COX2, FC 23.625, FDR 7.00x10-4),
Transcriptome Analysis of Hyperoxia Induced Lung Injury
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Fig 1. HE staining and lung injury score. A-B: HE staining of a pressure fixed lung of pups held in normoxia (A) or hyperoxia (B) for 7 days of life. In the
magnification square, neutrophils are marked by the arrows. C: lung injury score assessing 5 different parameters: neutrophils in alveolar airspace,
neutrophils in the interstitial space, hyaline membranes, proteinaceous debris filling the airspace, alveolar septal thickening.
doi:10.1371/journal.pone.0136569.g001
Fig 2. Heat map of differentially expressed genes. Animals held in normoxia (to the left, purple) or in hyperoxia (to the right, green) with FC+-2 and FDR
<0.01. Color intensity displayed in the heat map are the Log2 transformed RPKM gene expression value. These are normalized to relative low (green) and
high (red) signal intensities shown in the heat map key.
doi:10.1371/journal.pone.0136569.g002
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nitric oxide synthase 2 (NOS2, FC -8.495, FDR 1.90x10-5), granulocyte colony stimulating fac-
tor (G-CSF or CSF3, FC 17.090, FDR 2.30x10-3) and chemokines (C-C motif) ligand 2 (CCL2,
FC 148.355, FDR 1.20x10-5) and (C-X-C motif) ligand 8 (CXCL8 or IL8, FC 37.831, FDR
2.63x10-5).(Fig 3) Upstream analysis highlights tumor necrosis factor-alfa (TNFα) as a major
regulator (z-score 4.465). Downstream effectors of the TNFα-pathway include inflammatory
mediators (IL1A, IL1B) but also molecules involved in vasculogenesis (vascular endothelial
growth factor A (VEGFA), angiopoietin 2 (ANGPT2)), lung development (secreted phospho-
protein 1 (SPP1), caveolin 1 (CAV1), dickkopf WNT signaling pathway inhibitor 1 (DKK1),
peroxisome proliferator-activated receptor γ (PPARγ)) and ROS metabolism (cytochrome
P450 1A1 (CYP1A1), superoxide dismutase 2 (SOD2)) (S3 Table). Nuclear factor of kappa
light polypeptide gene enhancer in B-cells 1 (NF-κB, z-score 2.952), the intracellular transcrip-
tional effector of TNFα is also recognized as an activated upstream regulator. Other signifi-
cantly dysregulated inflammatory upstream regulators are interferon γ (IFNγ) and several
other interleukins (1A, 1B, 2, 3, 4, 5, 6, 12B, 17A, 17F, 18) albeit with lower z-scores (2.756,
3.269, 4.525, 2.004, 3.235, 2.247, 2.131, 2.369, 2.049, 2.658, 2.574, 2.348 resp.). The central mol-
ecules involved in the inflammatory pathway have been displayed in Fig 3.
Lung development. Molecules involved in lung development which are dysregulated in
our model are shown in Fig 4. Central molecules in this network are PPARγ (FC 4.268, FDR
2.90x10-3), SPP1 or osteopontin (FC 28.159, FDR 3.30x10-3), CAV1 (FC -6.282, FDR 3.10x10-
5), NOS2 and VEGFA. Other highly dysregulated molecules in this network are DKK1 (FC
Table 1. Upregulated molecules. Ten most upregulated molecules in our dataset; FC: fold change, FDR: false discovery rate.
Rank IPA name Full name FC FDR
1 RLN1 Relaxin 1 235.786 1.04x10-5
2 MT-ND4L NADH dehydrogenase subunit 4L 153.771 6.80x10-3
3 CCL2 Chemokine (C-C motif) ligand 2 148.355 1.20x10-5
4 MMP3 Matrix metalloproteinase 3 100.723 7.57x10-5
5 BIRC 3 Baculoviral IAP repeat containing 3 53.728 2.48x10-5
6 PTX3 Pentraxin 3, long 43.956 4.00x10-4
7 SRXN1 Sulfiredoxin 1 42.437 2.00x10-5
8 CXCL8 Chemokine (C-X-C motif) ligand 8 37.831 2.63x10-5
9 DKK1 Dickkopf WNT signaling pathway inhibitor 1 34.030 7.57x10-5
10 LIF Leukemia inhibitory factor 1 33.378 6.00x10-4
doi:10.1371/journal.pone.0136569.t001
Table 2. Down regulated molecules. Ten most down regulated molecules in our dataset; FC: fold change, FDR: false discovery rate.
Rank IPA abbreviation Name FC FDR
1 VIPR1 Vasoactive intestinal peptide receptor 1 -38.476 2.69x10-5
2 C2orf40 Chromosome 2 open reading frame 40 -32.645 1.00x10-4
3 ACE Angiotensin I converting enzyme -26.315 8.19x10-6
4 CD300LG CD300 molecule-like family, member g -22.293 1.39x10-5
5 SCBG3A1 Secretoglobulin, family 3A, member 1 -21.677 8.40x10-3
6 S100A1 S100 calcium binding protein A1 -19.873 3.59x10-5
7 CYP1A1 Cytochrome 450, family 1, subfamily A, polypeptide 1 -17.727 2.00x10-4
8 COLEC10 Collectin subfamily member 10 (C-type lectin) -15.835 2.00x10-4
9 CA4 Carbonic anhydrase IV -14.724 5.00x10-4
10 APLNR Apelin receptor -14.407 4.38x10-5
doi:10.1371/journal.pone.0136569.t002
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34.030, FDR 7.57x10-5) and angiotensin I converting enzyme (ACE, FC -26.315, FDR 8.19x10-
6). Our upstream analysis identified KLF2 (z-score -2.396) as an important inhibited transcrip-
tion factor. Downstream effectors of KLF2 include mediators of inflammation (CCL2, CXCL8,
PTGS2), vasculogenesis (ANGPT2) and lung development (PPARγ, ACE).(S4 Table)
Vasculogenesis. VEGFA (FC -5.539, FDR 1.00x10-4) is down regulated in our model. TEK
tyrosine kinase (TEK or TIE2, FC -7.844, FDR 1.90x10-5) and tyrosine kinase with immuno-
globulin-like and EGF-like domains 1 (TIE1, FC -6.540, FDR 1.82x10-5), the molecular recep-
tors of the angiopoetins, are down regulated while angiopoetin 2 (ANGPT2, FC 12.089, FDR
7.00x10-4, z-score 2.612), a receptor antagonist, is upregulated and also recognized as a signifi-
cantly activated upstream regulator.
ROS metabolism. Several enzymes involved in scavenging and detoxifying the reactive oxy-
gen species are upregulated, like superoxide dismutase 2 (SOD2, FC 2.349, FDR 8.90x10-3), thior-
edoxin reductase 1 (TXNRD1, FC 7.262, FDR 1.20x10-3) and sulfiredoxin 1 (SRXN1, FC 42.437,
FDR 2.00x10-5). Furthermore several cytochrome P450 (CYP) enzymes are down regulated, espe-
cially CYP1A1 (FC -17.727, FDR 2.00x10-4). A major upstream regulator influencing the above
mentioned enzymes is nuclear factor erythroid 2-like 2 (NFE2L2, z-score 4.796), downstream
effectors include inflammatory mediators (IL1B, PTSG2, . . .) as well as VEGFA (S5 Table).
Table 3. Upstream regulators. Transcription regulators, recognized to be upstream regulators (z-score +-2), with actual fold change, z-score, p-value of
overlap and number of downstream effectors.
IPA ID Entrez Gene Name FC Z-score p-value of overlap # of DTM
Activated upstream transcription factors
NFE2L2 nuclear factor, erythroid 2-like 2 4.796 3.80x10-13 76
CREB1 cAMP responsive element binding protein 1 3.661 5.10x10-8 79
RELA v-rel avian reticuloendotheliosis viral oncogene homolog A 2.998 1.25x10-5 49
NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 2.952 2.15x10-3 29
CDKN2A cyclin-dependent kinase inhibitor 2A 2.808 1.67x10-5 33
ATF4 Activating transcription factor 4 2.637 2.490 1.59x10-14 38
SMAD2 SMAD family member 2 2.425 1.00 6
KDM5B lysine (K)-specific demethylase 5B 2.400 4.19x10-4 21
MYC v-myc avian myelocytomatosis viral oncogene homolog 3.143 2.359 1.59x10-12 136
HMGB1 high mobility group box 1 2.303 6.46x10-2 10
MAFK v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K 2.170 1.00x10-2 5
EHF ets homologous factor 2.121 1.35x10-1 9
MAFG v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G 2.000 7.58x10-3 5
MAFF v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F 2.000 9.41x10-3 4
Inhibited upstream transcription factors
TWIST1 twist family bHLH transcription factor 1 -3.182 8.83x10-8 32
GATA2 GATA binding protein 2 -2.724 3.03x10-6 19
KLF2 Kruppel-like factor 2 -2.396 1.42x10-6 28
PRDM1 PR domain containing 1, with ZNF domain -2.255 5.26x10-3 17
NEUROG3 neurogenin 3 -2.219 1.00 5
HOXA7 homeobox A7 -2.200 8.52x10-2 5
HOXA9 homeobox A9 -2.183 1.74x10-1 18
PLAG1 pleiomorphic adenoma gene 1 -2.164 4.62x10-3 11
GLI2 GLI family zinc finger 2 -2.159 6.27x10-2 11
NEUROG1 neurogenin 1 -2.111 1.63x10-2 11
DTM: dysregulated target molecules
doi:10.1371/journal.pone.0136569.t003
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Discussion
Under the assumption that a rabbit model has several advantages over rodent models for
studying BPD with regard to lung development and the potential of experimental therapeutic
interventions, we used this preterm rabbit model [13] to comprehensively describe possible
pathways involved in the pathophysiology of BPD using modern techniques. Herein, we used
whole transcriptome analysis as this offers an comprehensive amount of expression informa-
tion, that allows to document the intricate and complex processes that occur in the damaged
developing lung. Lung injury score demonstrated results that parallel lung damage seen in clin-
ical BPD-samples.[2] This confirms the relevance of insights in the molecular mechanisms of
BPD obtained in our model. We focused on four relevant biological networks in this context:
inflammation, lung development, vasculogenesis and ROS metabolism.
Several inflammatory mediators were significantly dysregulated in our model, confirming
an important role for inflammation in the pathogenesis of hyperoxia-induced lung injury. The
pattern of dysregulation of these molecules is consistent with a pro-inflammatory state. This is
in line with data from other animal models [21] and clinical studies.[22] The increased TNFα-
activity induces many of the transcriptional changes seen in our model, some of these down-
stream mediators have been described in hyperoxia exposed term rabbit lungs.[23] It remains
unclear if this TNFα-activity is increased as a protective pathway or merely secondary to the
inflammation in the preterm lung. Experimental therapy both with TNFα and anti-TNFα
Table 4. Dysregulated genes of special interest. Dysregulated genes of special interest for hyperoxia-induced lung injury; in order of appearance; FC:
fold change, FDR: false discovery rate.
IPA ID Full Name FC FDR
Inflammation
IL1A Interleukin 1, alpha 6.864 3.60x10-3
IL1B Interleukin 1, beta 5.092 3.70x10-3
PTGS2 Prostaglandin-endoperoxide synthase 2 23.625 7.00x10-4
NOS2 Nitric oxide synthase 2, inducible -8.495 1.90x10-5
CSF3 Colony stimulating factor 3 (granulocyte) 17.090 2.30x10-3
CCL2 Chemokine (C-C motif) ligand 2 148.355 1.20x10-5
CXCL8 Chemokine (C-X-C motif) ligand 8 37.831 2.63x10-5
Lung development
PPARG Peroxisome proliferator-activated receptor gamma 4.268 2.90x10-3
SPP1 Secreted phosphoprotein 1 28.159 3.30x10-3
CAV1 Caveolin 1, caveolae protein, 22kDa -6.282 3.10x10-5
DKK1 Dickkopf WNT signaling pathway inhibitor 1 34.030 7.57x10-5
ACE Angiotensin I converting enzyme -26.315 8.19x10-6
Vasculogenesis
VEGFA Vascular endothelial growth factor A -5.539 1.00x10-4
TEK TEK tyrosine kinase, endothelial -7.844 1.90x10-5
TIE1 Tyrosine kinase with immunoglobulin-like and EGF-like domains 1 -6.540 1.82x10-5
ANGPT2 Angiopoetin 2 12.089 7.00x10-4
ROS metabolism
SOD2 Superoxide dismutase 2, mitochondrial 2.349 8.90x10-3
TXNRD1 Thioredoxin reductase 1 7.262 1.20x10-3
SRXN1 Sulfiredoxin 1 42.437 2.00x10-5
CYP1A1 Cytochrome 450, family 1, subfamily A, polypeptide 1 -17.727 2.00x10-4
doi:10.1371/journal.pone.0136569.t004
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show an improvement in rats exposed to hyperoxia.[24,25] To date this has not been corrobo-
rated in larger animal models.
Many preclinical studies have reported on molecules involved in lung development [26–29]
that can account for the developmental arrest in BPD. Several of these lung development mole-
cules are also dysregulated in our model.(Fig 4) PPARγ, which was also an upregulated mole-
cule in our study, is important for normal lung maturation.[30] Furthermore, beneficial effects
Fig 3. Network of dysregulated molecules involved in IPA-function: ‘Inflammatory Response’. The following molecules play a central role: IL1A (FC
6.864), IL1B (FC 5.092), PTSG2 (FC 23.625), NOS2 (FC -8.495), CXCL8 (FC 37.831) and CCL2 (FC 148.355). In order to increase readability, only
molecules with a FC of +/- 4 and 3 or more connections are shown in this figure.
doi:10.1371/journal.pone.0136569.g003
Transcriptome Analysis of Hyperoxia Induced Lung Injury
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Fig 4. Network of dysregulated molecules involved in IPA-function ‘Formation of lung’. Central, broadly connected molecules are SPP1 (FC 28.159),
CAV1 (FC -6.282), PPARγ (FC 4.268), NOS2 (FC -8.495) and VEGFA (FC 5.539). Relevant mediators of lung development mentioned in the following
references are added [26,27,30,34].
doi:10.1371/journal.pone.0136569.g004
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have been achieved with stimulation of PPARγ, e.g. by rosiglitazone in the rat model of hyper-
oxia-induced lung injury.[31–33] A second upregulated molecule is DKK1, which is an inhibi-
tor of WNT-signaling. Its known involvement in branching morphogenesis and alveolization
could account for a role in the developmental arrest of BPD.[28,34] Other dysregulated factors
of pulmonary development include SPP1 (downregulated during secondary septation [27]),
CAV1(involved in alveolar septation [35] and acute lung injury [36]) and ACE (involved in
secondary septation [37]).
We also suggest a role for KLF2, which we identified as an important upstream regulator. It
is highly expressed in adult mouse lung tissue and was demonstrated to be important for late
stage lung development (saccular and alveolar phase).[38] Furthermore, KLF2 is involved in
endothelial homeostasis and angiogenesis [39] and has negative regulatory effects on immune
cell activation.[40]
Normal lung development depends, certainly in the later stages, on vasculogenesis and the
development of mesenchymal structures: blood vessels and respiratory epithelium are in con-
stant interaction. Several molecular factors responsible for angiogenesis in the lung [26] are
changed in our hyperoxia model. VEGFA seems a central molecule in most of our generated
networks. The administration of VEGFA to attenuate lung damage has been tried in different
models with varying results.[41,42] Furthermore knockdown of VEGF abolishes the protective
effects of mesenchymal stem cells in a rat model of hyperoxic lung injury thereby demonstrat-
ing the critical role of VEGF.[43]
The upregulation of several enzymes involved in scavenging and detoxifying of ROS can be
considered as protective against the potential adverse effects of hyperoxia. NFE2L2 plays a crit-
ical role in the induction of this response.[44] Another important player we identified, is
CYP1A1. Induction of CYP1A1 via the aryl hydrocarbon receptor (AHR) pathway, using β-
naphthoflavone or omeprazole attenuates hyperoxic lung injury, which suggests a protective
effect of CYP1A1.[45,46]
We acknowledge certain limitations of our study. First, in this model we use only hyperoxia
to create lung injury. This is an imperfect approximation for human ‘new’ BPD.[1,47] In
human BPD, several other factors (barotrauma, infections, malnutrition, fluid imbalance, ante-
natal corticosteroids, surfactant, . . .) are involved, yet are not included in this experimental
model. Secondly, there are some methodological limitations. mRNA sequencing was per-
formed on whole, mixed, lung tissue which offers an overview of expression changes in all pul-
monary cell types. This results in loss of ‘spatial resolution’ as specific up regulation in
individual cell types constituting the airways, vasculature and parenchyma cannot be quanti-
fied in this manner. Furthermore, our samples were only examined at a single time point (7
days of hyperoxic exposure), a loss of temporal resolution has to be considered as well.
Although in our previous study no functional differences were found between term and pre-
term animals held in normoxia [13], no transcriptome analysis has been performed on term
animals. Some of the expressional differences might be explained by prematurity alone without
a clear hyperoxic cause. A final limitation is the use of selective filtering of the obtained results.
First, filtering for small RPKM’s and fold changes may result in the loss of meaningful subtle
dysregulated master switch molecules. The used software, IPA (Upstream Regulator Analysis
and Network Generation Algorithm) is also dependent on prior knowledge and many expres-
sion-regulating relationships remain still to be discovered or described. This may bias our anal-
ysis, in favor of molecules which have been frequently investigated.
Despite these theoretical limitations, other results of our experiment show obvious similari-
ties with previous studies analyzing specific molecules which may be involved in the patho-
physiology of BPD.[27,48,49] The first two studies [27,48] examined the changes in expression
profile during the last stages of lung development in rats without any hyperoxic lung damage.
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Important genes which were upregulated during the saccular stage were those involved in
development. Both studies found the Wnt signaling pathway to be affected by different genes
like Fzd1 (frizzled-1) or Ptn (pleiotrophin). Our data demonstrated DKK1, an inhibitor of Wnt
signaling to be upregulated after exposure to hyperoxia. In the study of Bhattacharya [49]
whole lung tissue was used from mice exposed to 100% hyperoxia for 10 days. They found Ahr
to be a key regulator in the pathophysiology of hyperoxic lung damage. This receptor is known
to activate CYP1A1, one of the main dysregulated molecules in our database. Furthermore,
Cdkn1a (cyclin-dependent kinase inhibitor 1a), which is a cell cycle regulator, is upregulated
both in mice as in our rabbit lung tissue. The exact mechanism how this gene is involved in the
pathophysiology of hyperoxic lung injury remains to be determined.
To conclude, our study is the first to perform whole transcriptome analysis on hyperoxia-
induced, preterm rabbit lung tissue identifying several central molecular mediators. The major
pathophysiological features of BPD we identified are inflammation, lung developmental arrest,
dysregulated vasculogenesis and increased ROS metabolism. We will use the molecular master
switches revealed in this analysis for the future definition of novel preventive strategies to
avoid or reduce the occurence of BPD.
Supporting Information
S1 Table. All dysregulated transcripts. FC: fold change, FDR: false discovery rate.
(XLSX)
S2 Table. All activated and inhibited upstream regulators. FC: fold change, z-score and p-
value of overlap.
(XLSX)
S3 Table. Downstream effectors of TNFα. FC: fold change.
(XLSX)
S4 Table. Downstream effectors of KLF2. FC: fold change.
(XLSX)
S5 Table. Downstream effectors of NFE2L2. FC: fold change.
(XLSX)
Acknowledgments
We would like to thank Julio Finalet Ferreiro for the help using the array studio software.
Author Contributions
Conceived and designed the experiments: JR TS JD JT PB. Performed the experiments: JR TS JJ
TN PB. Analyzed the data: JR TS TN JJ PB. Contributed reagents/materials/analysis tools: PB.
Wrote the paper: JR TS JT JD.
References
1. Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM (2006) Pathogenesis of bronchopulmonary dys-
plasia. Semin Perinatol 30: 171–178. PMID: 16860156
2. Coalson JJ (2006) Pathology of bronchopulmonary dysplasia. Semin Perinatol 30: 179–184. PMID:
16860157
3. Schmolzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY (2013) Non-invasive versus inva-
sive respiratory support in preterm infants at birth: systematic review and meta-analysis. Bmj 347:
f5980. doi: 10.1136/bmj.f5980 PMID: 24136633
Transcriptome Analysis of Hyperoxia Induced Lung Injury
PLOS ONE | DOI:10.1371/journal.pone.0136569 August 28, 2015 12 / 15
4. Kapadia VS, Chalak LF, Sparks JE, Allen JR, Savani RC, Wyckoff MH (2013) Resuscitation of preterm
neonates with limited versus high oxygen strategy. Pediatrics 132: e1488–1496. doi: 10.1542/peds.
2013-0978 PMID: 24218465
5. Jensen EA, Schmidt B (2014) Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin
Mol Teratol 100: 145–157. doi: 10.1002/bdra.23235 PMID: 24639412
6. VomHove M, Prenzel F, Uhlig HH, Robel-Tillig E (2013) Pulmonary outcome in former preterm, very
low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J
Pediatr 164: 40–45.e44. doi: 10.1016/j.jpeds.2013.07.045 PMID: 24055328
7. Su BH, Chiu HY, Lin TW, Lin HC (2005) Interleukin-8 in bronchoalveolar lavage fluid of premature
infants at risk of chronic lung disease. J Formos Med Assoc 104: 244–248. PMID: 15909061
8. Vento G, Tirone C, Lulli P, Capoluongo E, Ameglio F, Lozzi S, et al. (2009) Bronchoalveolar lavage fluid
peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia. Inten-
sive Care Med 35: 2115–2124. doi: 10.1007/s00134-009-1646-6 PMID: 19779697
9. Auten RL Jr., Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH (2001) Anti-neutrophil chemokine pre-
serves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol
281: L336–344. PMID: 11435208
10. Jiang JS, Lang YD, Chou HC, Shih CM, WuMY, Chen CM, et al. (2012) Activation of the renin-angio-
tensin system in hyperoxia-induced lung fibrosis in neonatal rats. Neonatology 101: 47–54. doi: 10.
1159/000329451 PMID: 21791939
11. Weichelt U, Cay R, Schmitz T, Strauss E, Sifringer M, Bührer C, et al. (2013) Prevention of hyperoxia-
mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J 41: 966–973. doi: 10.1183/
09031936.00012412 PMID: 22878872
12. Pringle KC (1986) Human fetal lung development and related animal models. Clin Obstet Gynecol 29:
502–513. PMID: 3757332
13. Richter J, Toelen J, Vanoirbeek J, Kakigano A, Dekoninck P, Verbeken E, et al. (2014) Functional
assessment of hyperoxia-induced lung injury after preterm birth in the rabbit. Am J Physiol Lung Cell
Mol Physiol 306: L277–283. doi: 10.1152/ajplung.00315.2013 PMID: 24375793
14. Bhattacharya S, Mariani TJ (2013) Systems biology approaches to identify developmental bases for
lung diseases. Pediatr Res 73: 514–522. doi: 10.1038/pr.2013.7 PMID: 23314295
15. Mascaretti RS, Mataloun MM, Dolhnikoff M, Rebello CM (2009) Lung morphometry, collagen and elas-
tin content: changes after hyperoxic exposure in preterm rabbits. Clinics (Sao Paulo) 64: 1099–1104.
16. Mataloun MM, Leone CR, Mascaretti RS, Dohlnikoff M, Rebello CM (2009) Effect of postnatal malnutri-
tion on hyperoxia-induced newborn lung development. Braz J Med Biol Res 42: 606–613. PMID:
19578640
17. Mataloun MM, Rebello CM, Mascaretti RS, Dohlnikoff M, Leone CR (2006) Pulmonary responses to
nutritional restriction and hyperoxia in premature rabbits. J Pediatr (Rio J) 82: 179–185.
18. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, et al. (2011) An official
American Thoracic Society workshop report: features and measurements of experimental acute lung
injury in animals. Am J Respir Cell Mol Biol 44: 725–738. doi: 10.1165/rcmb.2009-0210ST PMID:
21531958
19. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian
transcriptomes by RNA-Seq. Nat Methods 5: 621–628. doi: 10.1038/nmeth.1226 PMID: 18516045
20. IPA. Available: http://pages.ingenuity.com/rs/ingenuity/images/0812%20upstream_regulator_
analysis_whitepaper.pdf.
21. Bhandari V (2014) Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth
Defects Res A Clin Mol Teratol 100: 189–201. doi: 10.1002/bdra.23220 PMID: 24578018
22. Viscardi RM (2012) Perinatal inflammation and lung injury. Semin Fetal Neonatal Med 17: 30–35. doi:
10.1016/j.siny.2011.08.002 PMID: 21855435
23. D'Angio CT, LoMonaco MB, Chaudhry SA, Paxhia A, Ryan RM (1999) Discordant pulmonary proin-
flammatory cytokine expression during acute hyperoxia in the newborn rabbit. Exp Lung Res 25: 443–
465. PMID: 10483526
24. White CW, Ghezzi P (1989) Protection against pulmonary oxygen toxicity by interleukin-1 and tumor
necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitors. Biotherapy 1:
361–367. PMID: 2518282
25. Tsan MF, White JE, Michelsen PB, Wong GH (1995) Pulmonary O2 toxicity: role of endogenous tumor
necrosis factor. Exp Lung Res 21: 589–597. PMID: 7588445
26. Rutter M, Post M (2008) Molecular Basis for Normal and Abnormal Lung Development. In: Bancalari E,
editor. The Newborn Lung. 1st ed. Philadelphia: Saunders Elsevier. pp. 3–41.
Transcriptome Analysis of Hyperoxia Induced Lung Injury
PLOS ONE | DOI:10.1371/journal.pone.0136569 August 28, 2015 13 / 15
27. Boucherat O, Franco-Montoya ML, Thibault C, Incitti R, Chailley-Heu B, Delacourt C, et al. (2007)
Gene expression profiling in lung fibroblasts reveals new players in alveolarization. Physiol Genomics
32: 128–141. PMID: 17911382
28. De Langhe SP, Sala FG, Del Moral PM, Fairbanks TJ, Yamada KM, Warburton D, et al. (2005) Dick-
kopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of
the mouse embryonic lung. Dev Biol 277: 316–331. PMID: 15617677
29. Wang Y, Santos J, Sakurai R, Shin E, Cerny L, Torday JS, et al. (2009) Peroxisome proliferator-acti-
vated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res 65:
150–155. doi: 10.1203/PDR.0b013e3181938c40 PMID: 19262292
30. Simon DM, Arikan MC, Srisuma S, Bhattacharya S, Tsai LW, Ingenito EP, et al. (2006) Epithelial cell
PPAR[gamma] contributes to normal lung maturation. FASEB J 20: 1507–1509. PMID: 16720732
31. Rehan VK, Sakurai R, Corral J, Krebs M, Ibe B, Ihida-Stansbury K, et al. (2010) Antenatally adminis-
tered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J
Physiol Lung Cell Mol Physiol 299: L672–680. doi: 10.1152/ajplung.00240.2010 PMID: 20729387
32. Rehan VK, Wang Y, Patel S, Santos J, Torday JS (2006) Rosiglitazone, a peroxisome proliferator-acti-
vated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pul-
monol 41: 558–569. PMID: 16617452
33. Lee HJ, Lee YJ, Choi CW, Lee JA, Kim EK, Kim HS, et al. (2014) Rosiglitazone, a peroxisome prolifera-
tor-activated receptor-gamma agonist, restores alveolar and pulmonary vascular development in a rat
model of bronchopulmonary dysplasia. Yonsei Med J 55: 99–106. doi: 10.3349/ymj.2014.55.1.99
PMID: 24339293
34. Konigshoff M, Eickelberg O (2010) WNT signaling in lung disease: a failure or a regeneration signal?
Am J Respir Cell Mol Biol 42: 21–31. doi: 10.1165/rcmb.2008-0485TR PMID: 19329555
35. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, et al. (2001) Loss of caveolae, vascular
dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449–2452.
PMID: 11498544
36. Jin Y, Lee SJ, Minshall RD, Choi AM (2011) Caveolin-1: a critical regulator of lung injury. Am J Physiol
Lung Cell Mol Physiol 300: L151–160. doi: 10.1152/ajplung.00170.2010 PMID: 21097526
37. Capelari DN, Sanchez SI, Ortega HH, Ciuffo GM, Fuentes LB (2012) Effects of maternal captopril treat-
ment during late pregnancy on neonatal lung development in rats. Regul Pept 177: 97–106. doi: 10.
1016/j.regpep.2012.05.092 PMID: 22587910
38. Wani MA, Wert SE, Lingrel JB (1999) Lung Kruppel-like factor, a zinc finger transcription factor, is
essential for normal lung development. J Biol Chem 274: 21180–21185. PMID: 10409672
39. Atkins GB, Jain MK (2007) Role of Kruppel-like transcription factors in endothelial biology. Circ Res
100: 1686–1695. PMID: 17585076
40. Das H, Kumar A, Lin Z, Patino WD, Hwang PM, Feinberg MW, et al. (2006) Kruppel-like factor 2 (KLF2)
regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A 103: 6653–6658. PMID:
16617118
41. Kunig AM, Balasubramaniam V, Markham NE, Seedorf G, Gien J, Abman SH (2006) Recombinant
human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal
hyperoxia. Am J Physiol Lung Cell Mol Physiol 291: L1068–1078. PMID: 16829629
42. Debeer A, Sbragia L, Vrancken K, Hendriks A, Roubliova X, Jani J, et al. (2010) Antenatal fetal VEGF
therapy to promote pulmonary maturation in a preterm rabbit model. Early Hum Dev 86: 99–105. doi:
10.1016/j.earlhumdev.2010.01.025 PMID: 20181445
43. Chang YS, Ahn SY, Jeon HB, Sung DK, Kim ES, Sung SI, et al. (2014) Critical role of vascular endothe-
lial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. Am J Respir Cell Mol
Biol 51: 391–399. doi: 10.1165/rcmb.2013-0385OC PMID: 24669883
44. Cho HY, Reddy SP, Kleeberger SR (2006) Nrf2 defends the lung from oxidative stress. Antioxid Redox
Signal 8: 76–87. PMID: 16487040
45. Couroucli XI, Liang YH, JiangW, Wang L, Barrios R, Yang P, et al. (2011) Prenatal administration of
the cytochrome P4501A inducer, Beta-naphthoflavone (BNF), attenuates hyperoxic lung injury in new-
born mice: implications for bronchopulmonary dysplasia (BPD) in premature infants. Toxicol Appl Phar-
macol 256: 83–94. PMID: 21745492
46. Shivanna B, JiangW, Wang L, Couroucli XI, Moorthy B (2011) Omeprazole attenuates hyperoxic lung
injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of
cytochrome P4501A enzymes. J Pharmacol Exp Ther 339: 106–114. doi: 10.1124/jpet.111.182980
PMID: 21768223
47. Jobe AH (2011) The new bronchopulmonary dysplasia. Curr Opin Pediatr 23: 167–172. PMID:
21169836
Transcriptome Analysis of Hyperoxia Induced Lung Injury
PLOS ONE | DOI:10.1371/journal.pone.0136569 August 28, 2015 14 / 15
48. Weng T, Chen Z, Jin N, Gao L, Liu L (2006) Gene expression profiling identifies regulatory pathways
involved in the late stage of rat fetal lung development. Am J Physiol Lung Cell Mol Physiol 291:
L1027–1037. PMID: 16798779
49. Bhattacharya S, Zhou Z, Yee M, Chu CY, Lopez AM, Lunger VA, et al. (2014) The genome-wide tran-
scriptional response to neonatal hyperoxia identifies Ahr as a key regulator. Am J Physiol Lung Cell Mol
Physiol 307: L516–523. doi: 10.1152/ajplung.00200.2014 PMID: 25150061
Transcriptome Analysis of Hyperoxia Induced Lung Injury
PLOS ONE | DOI:10.1371/journal.pone.0136569 August 28, 2015 15 / 15
